Xiaolei Liu
First Affiliated Hospital of Zhengzhou University(CN)
Publications by Year
Research Areas
Hepatocellular Carcinoma Treatment and Prognosis, Vascular Tumors and Angiosarcomas, Vascular Malformations and Hemangiomas, Cholangiocarcinoma and Gallbladder Cancer Studies, Genetic and Kidney Cyst Diseases
Most-Cited Works
- → The persistence of SARS-CoV-2 in tissues and its association with long COVID symptoms: a cross-sectional cohort study in China(2024)156 cited
- → ALCAT1 controls mitochondrial etiology of fatty liver diseases, linking defective mitophagy to steatosis(2014)152 cited
- → The Epigenetics of Alzheimer’s Disease: Factors and Therapeutic Implications(2018)147 cited
- → Endothelial epsin deficiency decreases tumor growth by enhancing VEGF signaling(2012)113 cited
- → Ablation of ALCAT1 Mitigates Hypertrophic Cardiomyopathy through Effects on Oxidative Stress and Mitophagy(2012)96 cited
- → Lung ultrasonography: an effective way to diagnose community-acquired pneumonia(2014)83 cited
- → Exosomal MicroRNA-126 from RIPC Serum Is Involved in Hypoxia Tolerance in SH-SY5Y Cells by Downregulating DNMT3B(2020)60 cited
- → The role of AMPK/mTOR/S6K1 signaling axis in mediating the physiological process of exercise-induced insulin sensitization in skeletal muscle of C57BL/6 mice(2012)54 cited
- → Genetic Reduction of Vascular Endothelial Growth Factor Receptor 2 Rescues Aberrant Angiogenesis Caused by Epsin Deficiency(2013)48 cited
- → Epsin is required for Dishevelled stability and Wnt signalling activation in colon cancer development(2015)48 cited